Answers are grounded in this paper and cite their sources.
Literature review analyzes socio-demographic and comorbidity factors affecting MDR-TB, suggesting implications for treatment adherence.
Multidrug-resistant tuberculosis (MDR-TB) poses a significant challenge in global TB control, caused by Mycobacterium tuberculosis strains resistant to first-line antibiotics isoniazid and rifampicin. According to WHO, an estimated 400,000 MDR-TB cases were reported worldwide in 2024. This literature review aims to analyze socio-demographic, comorbidity, lifestyle, and policy factors influencing MDR-TB occurrence by reviewing 20 studies conducted in Africa, Asia, Europe, Australia, and America. Employing a meta-analysis approach, the study identifies key risk factors, including medication non-adherence, history of diabetes mellitus (DM) and HIV comorbidities, and productive age. Findings highlight the importance of targeted community interventions, improved treatment adherence, and strengthened TB control programs. Evidence-based policies for early screening and integrated management, as well as adaptive intervention models, are necessary. Further research is recommended to evaluate community-based approaches and digital innovations in enhancing treatment success.
No takes yet. Share an insight, caveat, or question.
Azzahra et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: